The Due Diligence Imperative in the Era of Value-Based Reimbursement

BVResearch Pro
Training Event Transcripts
August 27, 2019
Todd A. Zigrang, MBA, MHA, FACHE, ASA
Jessica L. Bailey-Wheaton, Esq.
healthcare
healthcare valuation, healthcare, healthcare appraisal, due diligence, industry analysis

Summary

With the emergence of value-based reimbursement, such as accountable care organizations (ACOs), clinically integrated networks (CINs), and bundled payment models, which rely on achieving the “Triple Aim” of healthcare at lower cost, U.S. hospitals and other service providers are increasingly looking to change how services are being delivered by seeking more collaborative relationships with physicians. The rise of these emerging healthcare organizations (EHOs) to address value-based reimbursement initiatives has led to a growing number of complex transactions in the healthcare delivery marketplace, accompanied by increased federal and state regulatory scrutiny regarding the legal permissibility of these arrangements. Now, more than ever, conducting a level of due diligence appropriate to the scope and complexity of a given assignment is critical to the transactional risks (financial, operational, and regulatory) that may impact the development and defensibility of the valuation opinion. Join valuation expert Todd Zigrang and attorney Jessica Bailey-Wheaton for a discussion of the due diligence process of a healthcare transaction within the Four Pillars of Healthcare Valuation (i.e., regulatory, reimbursement, competition, and technology). They'll also provide participants a wealth of tips on publicly available resources to facilitate the process, as well as how to work with clients to obtain the requisite entity-specific data.
The Due Diligence Imperative in the Era of Value-Based Reimbursement
PDF, Size: 1,202 KB